REPORTING FROM ACTRIMS
Americas Committee for Treatment and Research in Multiple Sclerosis
West Palm Beach, Florida
FRIDAY, FEBRUARY 28
© 2020, Consortium of Multiple Sclerosis Centers. Published by Delaware Media Group, LLC. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, or Bristol-Myers Squibb.
Human glial progenitor cells (hGPCs), or stem cells, are able to differentiate into oligodendrocytes and remyelinate different types of demyelinated brain tissue in mice. University of Rochester researcher John Mariani, PhD, reported the findings at the ACTRIMS Forum on February 27.Dr. Mariani, a research scientist at the Center for Translational Neuromedicine at University of Rochester in Rochester, NY, presented his data on Thursday, February 27, at the ACTRIMS Forum in West Palm Beach, Florida.